TL;DR
This study reveals a novel mechanism by which the gut microbiota metabolite propionate protects against myocardial ischemia-reperfusion (I/R) injury. Propionate alleviates injury by modulating the Angiotensin II (Ang II) pathway, specifically through an interaction between caveolin-1 (CAV-1) and ACE2, mediated by the GPR41 receptor. This work suggests dietary interventions targeting gut flora could be a promising therapeutic strategy for I/R injury.
What Problem Does This Paper Address?
Myocardial ischemia-reperfusion (I/R) injury, a common complication following events like heart attacks or cardiac surgery, remains a significant clinical challenge with limited effective treatments. While the role of Angiotensin II (Ang II) in exacerbating this injury is known, the precise molecular mechanisms and potential therapeutic avenues are not fully understood. This paper investigates how gut microbiota, specifically the metabolite propionate, might mitigate I/R injury and explores the underlying molecular pathways involving Ang II, caveolin-1 (CAV-1), and ACE2.
Methods
The researchers employed a multi-pronged approach combining clinical observations, in vivo animal models, and molecular techniques:
- Clinical Study: Blood samples from patients undergoing cardiopulmonary bypass (CPB) surgery were analyzed for Ang II, CK-MB, and cTn-I levels at different time points to correlate Ang II levels with myocardial injury. Stool samples were also analyzed for propionate content.
- Animal Models:
- Myocardial I/R Model: Standardized surgical procedures were used to induce I/R injury in mice.
- Ang II Infusion: Mice were treated with Ang II to assess its direct impact on I/R injury.
- Gene Knockdown: Adeno-associated virus (AAV9) vectors were used to specifically knock down the expression of CAV-1, ACE2, or GPR41 in myocardial tissue.
- Propionate Administration: Mice were given propionate in their drinking water to evaluate its protective effects.
- Molecular and Cellular Techniques:
- Western Blotting: Used to measure protein expression levels of CAV-1, ACE2, and GPR41.
- Immunohistochemistry: Employed to visualize the spatial distribution and expression of CAV-1 and ACE2 in myocardial tissue.
- Co-immunoprecipitation (Co-IP): Performed to confirm direct protein-protein interactions between CAV-1 and ACE2.
- Echocardiography: Assessed cardiac function (LVEF, LVFS, LVESd, LVEDd).
- Biochemical Assays: Measured infarct size (TTC staining), SOD activity, and MDA activity as indicators of oxidative stress and tissue damage.
- Gas Chromatography/Mass Spectrometry (GC/MS): Used to quantify propionate levels in stool samples.
Datasets
Not discussed in the paper. The study primarily relies on experimental data generated from patient samples and animal models.
Key Insights and Ideas
- Ang II as a Key Aggravator: The study strongly reinforces the role of elevated Ang II in worsening myocardial I/R injury, both in clinical settings (CPB patients) and in mouse models.
- CAV-1 and ACE2 as Interacting Partners: A crucial finding is the direct physical interaction between CAV-1 and ACE2 in the heart. This interaction appears to be a critical regulatory axis in I/R injury.
- Opposing Roles of CAV-1 and ACE2: The research demonstrates that CAV-1 knockdown is protective against Ang II-induced I/R injury, while ACE2 knockdown exacerbates it. This suggests a delicate balance between these two proteins.
- Propionate's Protective Mechanism: The gut metabolite propionate emerges as a significant protective agent. It appears to counteract the detrimental effects of Ang II by influencing the CAV-1/ACE2 axis.
- GPR41 as the Propionate Receptor: The study identifies G-protein coupled receptor 41 (GPR41) as the key mediator through which propionate exerts its protective effects, linking dietary intake to cellular signaling.
- Gut-Heart Axis Connection: The clinical correlation between preoperative stool propionate levels and myocardial injury markers highlights the tangible link between gut health and cardiac outcomes.
Key Results
- Clinical Correlation: In CPB patients, higher Ang II levels at reperfusion (T3) were positively correlated with increased CK-MB and cTn-I levels, indicating greater myocardial injury. Conversely, preoperative stool propionate levels were negatively correlated with Ang II and injury markers.
- Ang II Exacerbation: Ang II infusion significantly increased myocardial infarct size, plasma CK-MB and cTn-I levels, and worsened cardiac function in mice.
- CAV-1/ACE2 Dynamics: Ang II infusion led to increased CAV-1 and decreased ACE2 expression in myocardial tissue. CAV-1 knockdown reversed Ang II-induced injury, while ACE2 knockdown worsened it.
- Propionate's Efficacy: Propionate treatment in mice significantly reduced infarct size, plasma injury markers, and improved cardiac function, while also increasing SOD activity and decreasing MDA activity.
- GPR41 Mediation: Knockdown of GPR41 abolished the protective effects of propionate, confirming its role as the mediator of propionate's action. GPR41 knockdown also reversed the beneficial changes in CAV-1 and ACE2 expression induced by propionate.
Limitations and Future Work
- Other SCFAs: The study focused on propionate (C3) but acknowledges that other short-chain fatty acids (SCFAs) might have similar effects, and their roles were not investigated.
- GPR41 Regulation: The precise mechanisms by which GPR41 regulates Ang II levels and its interaction with CAV-1 or ACE2 were not fully elucidated.
- Sex Differences: The study exclusively used male mice, and the influence of estrogen on the experimental outcomes was not considered.
- CAV-3 Role: While CAV-1 and CAV-3 are both caveolins involved in myocardial I/R injury, this study did not investigate the role or expression changes of CAV-3.
- Clinical Translation: The authors suggest that reasonable dietary interventions, such as increasing dietary fiber or consuming sodium propionate solutions, could be potential strategies for treating myocardial I/R injury. Further research into the clinical translation of these findings is warranted.
Summary updated